Disease: Atypical hemolytic uremic syndrome
- [Translated article] Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy
- "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy
- A Case of Atypical Hemolytic Uremic Syndrome Triggered by Acute Pancreatitis in a Patient with a Membrane Cofactor Protein (CD46) Genetic Variant
- A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy
- A pediatric case of atypical hemolytic uremic syndrome (aHUS): Could any infection play a triggering role?
- A Rare Case of Atypical Hemolytic Uremic Syndrome (aHUS) Precipitated by Dengue and the Treatment Landscape in Singapore
- A Rare Case of Atypical Hemolytic Uremic Syndrome (HUS) in an Adult Male: A Catastrophic Presentation
- A Rare Case of Autoimmune Disorder as a Trigger for Atypical Hemolytic Uremic Syndrome
- A Severe Form of Atypical Hemolytic Uremic Syndrome in a Two-Year-Old Girl: A Case Report
- Abbreviated protocol of plasma exchanges for patients with anti-factor H associated hemolytic uremic syndrome
- Adolescence-onset atypical hemolytic uremic syndrome: is it different from infant-onset?
- An Atypical Case of Hemolytic Uremic Syndrome Caused by Shiga Toxin Produced by Aeromonas spp
- An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group
- An unusual case of adult-onset still's disease complicated with anti-complement factor H antibodies associated atypical haemolytic uraemic syndrome
- Annual trends in atypical haemolytic uremic syndrome management in Japan and factors influencing early diagnosis and treatment: a retrospective study
- Anti-C5 monoclonal antibody treatment showing pathological resolution of complement-mediated atypical hemolytic uremic syndrome: a case report
- Anti-CFH-associated hemolytic uremic syndrome: do we still need plasma exchange?
- Anti-factor B antibodies in atypical hemolytic uremic syndrome
- Anti-factor H Autoantibody-Associated Hemolytic Uremic Syndrome: A Rare Entity in a Pediatric Patient
- Application of eculizumab, a terminal complement inhibitor, in the management of atypical hemolytic uremic syndrome in a 14-month-old Chinese pediatric patient: a case report
- Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies
- Atypical haemolytic uremic syndrome in a patient with severe Babesiosis
- Atypical hemolytic uremic syndrome during induction chemotherapy in neuroblastoma, a rare phenomenon or common congenital predisposition?
- Atypical hemolytic uremic syndrome in a child: A rare case report
- Atypical Hemolytic Uremic Syndrome: A Nationwide Colombian Pediatric Series
- Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report
- Bilateral Retinal Venous Occlusion in Atypical Hemolytic-Uremic Syndrome Due to Complement Factor H Mutation
- Bronchopleural fistula management in a pediatric patient requiring extracorporeal membrane oxygenation
- Can eculizumab be an option in traditional treatment-resistant ulcerative colitis?
- Cardiac Manifestation in a Child With Atypical Hemolytic Uremic Syndrome
- Case presentation: a severe case of cobalamin c deficiency presenting with nephrotic syndrome, malignant hypertension and hemolytic anemia
- Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication
- Case Report: C3 deficiency in two siblings
- Characterization of patients with aHUS and associated triggers or clinical conditions: A Global aHUS Registry analysis
- Clinical characteristics and genetic profile of complement system in renal thrombotic microangiopathy in patients with severe forms of arterial hypertension
- Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS- real-world data
- Clinical presentation and management of atypical hemolytic uremic syndrome in Latin America: a narrative review of the literature
- Coagulation and complement crosstalk: molecular mechanisms of complement-mediated diseases
- Combined usage of serodiagnosis and O antigen typing to isolate Shiga toxin-producing <em>Escherichia coli</em> O76:H7 from a hemolytic uremic syndrome case and genomic insights from the isolate
- Combined usage of serodiagnosis and O antigen typing to isolate Shiga toxin-producing Escherichia coli O76:H7 from a hemolytic uremic syndrome case and genomic insights from the isolate
- Comparative characteristics of the complement system in patients with C3-glomerulopathy and atypical hemolytic uremic syndrome of chronic course who suffered an acute episode of thrombotic microangiopathy
- Comprehensive functional characterization of complement factor I rare variant genotypes identified in the SCOPE geographic atrophy cohort
- Correction to: Adolescence-onset atypical hemolytic uremic syndrome: is it different from infant-onset?
- Crovalimab: First Approval
- Diacylglycerol kinase-ε is S-palmitoylated on cysteine in the cytoplasmic end of its N-terminal transmembrane fragment
- Diagnostic Challenges and Emerging Pathogeneses of Selected Glomerulopathies
- Diffuse alveolar haemorrhage due to atypical hemolytic uremic syndrome (aHUS) associated with COVID-19
- Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics
- Eculizumab for pregnancy-related atypical hemolytic uremic syndrome
- Efficacy and Safety of Eculizumab in Enteroaggregative <em>E. coli</em> Associated Hemolytic Uremic Syndrome
- Efficacy and Safety of Eculizumab in Enteroaggregative E. coli Associated Hemolytic Uremic Syndrome
- End stage renal disease in patient with microscopic polyangiitis and atypical hemolytic-uremic syndrome arose 3 weeks after the third dose of anti-SARS-CoV2 vaccine mRNA-1273: A case report with literature revision
- Epidemiology, Management, and Outcome of Atypical Hemolytic Uremic Syndrome in an Omani Cohort
- Ex vivo C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy
- Ex Vivo Test of Complement Dysregulation in Atypical Hemolytic Uremic Syndrome Kidney Transplant patients: A Pilot Study
- Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition
- Genetic and virulence characteristics of hybrid Shiga toxin-producing and atypical enteropathogenic Escherichia coli strains isolated in South Korea
- Genetic Diagnosis of Adult Hemodialysis Patients With Unknown Etiology
- Hemolytic Uremic Syndrome
- Hemolytic Uremic Syndrome: A COVID-19 Vaccine Reaction Case Report
- HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies
- Hot Spot of Complement Factor I Rare Variant p.Ile357Met in Patients With Hemolytic Uremic Syndrome
- How We Interpret Thrombosis with Thrombocytopenia Syndrome?
- Kidney involvement in rare hereditary diseases
- Kidney Transplantation in Patients With aHUS: A Comparison of Eculizumab Prophylaxis Versus Rescue Therapy
- Life-Threatening Diffuse Alveolar Hemorrhage and Graft Failure in Atypical Hemolytic Uremic Syndrome with C3 Gene Mutation following Kidney Transplant
- Living with Atypical Hemolytic Uremic Syndrome in the Netherlands: Patient and Family Perspective
- Management of pediatric hemolytic uremic syndrome
- Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity
- Novel Heterozygous Missense Variants in Diacylglycerol Kinase Epsilon and Complement Factor I: Potential Pathogenic Association With Atypical Hemolytic Uremic Syndrome
- O80:H2-Associated Hemolytic Uremic Syndrome without Hemorrhagic Colitis: A Case Report
- Outcome of atypical hemolytic uremic syndrome: role of triggers and complement abnormalities in the response to C5 inhibition
- Plasma Exchange in Postpartum Hemorrhage (PPH)-Associated Thrombotic Microangiopathy (TMA): A Case Report
- Pregnancy-Associated Atypical Hemolytic Uremic Syndrome Successfully Treated with Ravulizumab: A Case Report
- Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Case Report with MCP Gene Mutation and Successful Eculizumab Treatment
- Pregnancy-associated atypical hemolytic uremic syndrome. Case report
- Protein-losing enteropathy as a new phenotype in atypical hemolytic uremic syndrome caused by CD46 gene mutation
- Rational use of eculizumab in secondary atypical hemolytic uremic syndrome
- Ravulizumab facilitates reduced burden of vascular access, a major benefit in paediatric atypical haemolytic uraemic syndrome
- Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials
- Recent data on atypical hemolytic uremic syndrome associated with pregnancy, kidney transplantation or hypertensive emergency
- Recommendations for the individualised management of atypical hemolytic uremic syndrome in adults
- Recurrent complement-mediated Hemolytic uremic syndrome after kidney transplantation
- Recurrent disease after pediatric renal transplantation
- Retraction: Novel Variation in CFB Adult Onset Atypical Hemolytic Uremic Syndrome: A Case Report and Review
- Severe hemolysis, elevated liver enzymes, and low platelet syndrome requiring differentiation of thrombotic microangiopathy: Four cases from a nationwide survey in Japan
- Successful 13-year ongoing remission with C5 inhibitor therapy following renal transplant in atypical hemolytic uremic syndrome
- Successful diagnosis and treatment of recurrent atypical hemolytic uremic syndrome posttransplantation caused by the heterozygous deletion of CFH in a patient with end-stage kidney disease of uncertain etiology
- Successful Management of Atypical Hemolytic-Uremic Syndrome in Pregnancy Using Eculizumab: A Case Review
- Systemic lupus erythematosus presenting with atypical hemolytic uremic syndrome: a case report and review of the literature
- The complement system in the pathogenesis and progression of kidney diseases: What doesn't kill you makes you older
- The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms
- The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome
- The unanswered question. When to undertake a maternity journey?
- Thrombotic Microangiopathy as a Life-Threatening Complication of Long-Term Interferon Beta Therapy for Multiple Sclerosis: Clinical Phenotype and Response to Treatment-A Literature Review
- Thrombotic Microangiopathy Post-COVID-19 Vaccination
- Various phenotypes of postpartum atypical hemolytic uremic syndrome: the role of genetic testing in determining prognosis. Case report
- What came first, atypical hemolytic uremic syndrome or malignant hypertension: a clinical dilemma
- When a Headache Is Not Just Hypertension: A Case of Atypical Hemolytic Uremic Syndrome in a Young Patient